{
  "_id": "8a5be0f820e8364befeb7920726b277f9d8d06978d97b7b094734fc766301a2d",
  "feed": "market-watch",
  "title": "Scotts Miracle-Gro says cannabis slowdown and supply chain problems impacted sales",
  "text": "<p>Hawthorne is a wholly-owned subsidiary of Scotts Miracle-Gro SMG specializing in items for indoor and hydroponic growing.</p><p>Adjusted earnings for the fiscal year are expected to be in the range of $8.50 to $8.90.</p><p>The FactSet consensus is for full-year sales of $4.9 billion and EPS of $8.58.</p><p>See: Investors in cannabis companies burned by stock-market losses in 2021 even as the pot business grows</p><p>Chief Financial Officer Cory Miller said in a statement that the company expects the supply chain problems to be resolved by the end of January and pre-orders for the second and third quarters are healthy.</p><p>“However, the decline we've seen in the first quarter, against a 71% growth comparison a year ago, is greater than we had anticipated. Based on our current view of the market, we are lowering our full-year sales guidance for Hawthorne to a range of 0 to minus 10% on a year-over-year basis,” he said.</p><p>Scotts Miracle-Gro also announced two acquisitions on Tuesday: Luxx Lighting for $215 million, and True Liberty Bags, a liners and storage company for the hydroponic market, for $10 million.</p><p>Scotts says Luxx will add $100 million in sales and $20 million in operating income annually to Hawthorne's business. Luxx is expected to generate $75 million in sales for the remainder of fiscal 2022, and is expected to be earnings neutral for the first year. Hawthorne's full-year sales guidance includes consideration of the Luxx acquisition, and “assumes a return to growth during the second half of the year,” Miller said.</p><p>Want intel on all the news moving markets before the day starts? Sign up for our daily Need to Know newsletter.</p><p>Sign up for Need to Know</p><p>Raymond James analysts followed by reiterating their strong buy rating on Scotts' stock but by shaving $5 from the price target, bringing it to $195.</p><p>“Our strong buy rating on the shares of Scotts Miracle-Gro reflects both our long-term optimism regarding the company's Hawthorne hydroponics segment, as well as our view that much of the recent expansion in the addressable market for its U.S.,” wrote Raymond James in a note. “Consumer segment during the COVID pandemic should prove sustainable.”</p><p>Scotts announced in August 2021 that it had acquired HydroLogic Purification Systems in a $65 million deal and Rhizoflora, a nutrient company that was added to the Hawthorne portfolio.</p><p>Scotts Miracle-Gro is scheduled to host its annual meeting on Jan. 24 and announce first-quarter results on Feb. 1, according to a FactSet calendar.</p><p>Scotts Miracle-Gro stock fell 2.8% in Tuesday trading, and has slumped 21.2% over the last year.</p><p>The S&amp;P 500 index SPX has gained 28.6% over the period.</p>",
  "published": "2022-01-05T07:54:00.000Z",
  "tags": [
    {
      "id": "US4581401001",
      "name": "Intel Corporation",
      "offsets": [
        {
          "start": 1527,
          "end": 1532
        }
      ],
      "nexusId": "10063594"
    }
  ]
}